The measure, passed in a 3-2 vote, restricts broadband companies' power to control download speeds.» Read More
In recent appearances, Hillary Clinton has delivered progressive messages but Wall Street is not alarmed, Politico's Ben White says.
Amgen's CEO provided an answer to Dan Loeb's recent suggestion that the biotechnology company be split up. In short, he said, it doesn't make sense.
Tesla's CEO Elon Musk took to Twitter to shoot down a Wall Street Journal article, calling the sales figures quoted in the article "incorrect."
Pfizer earnings topped analysts' expectations on Tuesday, helped by demand for its cancer drugs and medicines in emerging markets.
Yahoo's CEO has been aggressively looking for some high-level help to turn around the turnaround that has not yet yielded the results promised.
Executives see cybersecurity as a major concern, yet most don't prioritize technology investments, according to a new Deloitte Consulting survey.
DuPont reported a 52 percent jump in profit as operating margins rose in five of its seven businesses.
A Dallas nurse who was being treated for Ebola will discuss her discharge from an Atlanta hospital after tests showed she's virus-free.
U.S. single-family home prices rose in August on a year-over-year basis but fell short of expectations, a closely watched survey said on Tuesday.
Speculation is increasing that the Organization of Petroleum Exporting Countries will reverse course and cut production at its Thanksgiving meeting.
A nurse quarantined in NJ because of her contact with Ebola patients is headed to Maine, and a 5-year-old boy is being tested for the virus.
New Jersey Gov. Chris Christie mounted an impassioned defense of the decision to quarantine a healthcare worker who had contact with Ebola patients.
Most millionaires are concerned about inequality and nearly half support a higher minimum wage and more taxes on the rich, according to a new survey.
Interest rates will not only remain low, but could soon hit a ceiling in the near term, says Wall Street pro Scott Minerd.
The company announced a new line-up wearables and two of the devices include optical heart rate sensors, something new to Fitbits, Re/code reports.
Goldman Sachs has slashed its 2015 oil price forecasts, making it the most bearish among major financial institutions, following a near 25 percent fall in prices.
The roller coaster ride for Sarepta continues, as it's likely to file for approval of its muscular dystrophy drug in mid-2015.
Rates for a 30-year mortgage wavered near historical lows, but credit availability continues to be a problem for potential home buyers.
'Tis the season for charitable giving. Here's a look at popular crowdfunding campaigns that target problems ranging from Ebola to hunger.
New York's Ebola case has investors wondering if there will be any economic impact from the scare. If trends in Dallas are any indication, there could be.
Get the best of CNBC in your inbox
Llamas weren't the only things running wild today. "Mad Money" host Jim Cramer has a stock galloping higher.
Mad Money's Jim Cramer the impact the crushing of the domestic oil renaissance is going to have on the U.S. economy.
Faheem Hasnain, Receptos Inc. president and CEO, discusses the trials for its multiple sclerosis drug, Ozanimod, with Mad Money's Jim Cramer.